Jim Simons
IDYA icon

Jim Simons’s IDEAYA Biosciences IDYA Stock Holding History

Jim Simons’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-357,600
Closed -$5.86M – 3703
2025
Q1 		$5.86M Buy
357,600
+73,333
+26% +$1.56M 0.01% 1336
2024
Q4 		$7.31M Buy
284,267
+113,902
+67% +$3.22M 0.01% 1198
2024
Q3 		$5.4M Buy
170,365
+61,040
+56% +$2.31M 0.01% 1396
2024
Q2 		$3.84M Buy
+109,325
New +$4.33M 0.01% 1471
2022
Q2 		– Sell
-196,537
Closed -$2.2M – 4385
2022
Q1 		$2.2M Buy
+196,537
New +$2.9M ﹤0.01% 2171
2021
Q4 		– Sell
-29,600
Closed -$755K – 4044
2021
Q3 		$755K Sell
29,600
-39,000
-57% -$911K ﹤0.01% 2699
2021
Q2 		$1.44M Buy
68,600
+7,900
+13% +$162K ﹤0.01% 2465
2021
Q1 		$1.43M Sell
60,700
-78,700
-56% -$1.52M ﹤0.01% 2426
2020
Q4 		$1.95M Buy
139,400
+4,800
+4% +$65K ﹤0.01% 2128
2020
Q3 		$1.69M Buy
134,600
+25,500
+23% +$316K ﹤0.01% 2232
2020
Q2 		$1.55M Buy
+109,100
New +$860K ﹤0.01% 2317

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Jim Simons's IDYA Position: Q2 2025 in Review

Jim Simons sold out of IDEAYA Biosciences (IDYA) in Q2 2025, closing a stake of 357,600 shares — an estimated $5.86M sold.

Jim Simons first reported a position in IDYA in Q2 2020 and held it in 11 quarters. The position peaked at $7.31M in Q4 2024. 204 funds tracked by Wall St. Rank hold IDYA as of Q2 2025.

  • Jim Simons reported no remaining IDEAYA Biosciences position as of Q2 2025 after selling out during the quarter.
  • Jim Simons sold 357,600 IDEAYA Biosciences shares in Q2 2025, an estimated $5.86M.
  • Jim Simons first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 11 quarters.
  • Jim Simons's IDEAYA Biosciences position peaked at $7.31M in Q4 2024.
  • 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2025.

Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.